Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …

Immunoglobulin has been widely used in a variety of diseases, including primary and
secondary immunodeficiency diseases, neuromuscular diseases, and Kawasaki disease …

Immunoglobulin (IG) therapy is actually used for a broad range of diseases including
primary and secondary immunodeficiency disorders, and autoimmune diseases. This …

Intravenous immune globulin (IVIG) is an immune‐modulating biologic therapy that is
increasingly being used in neuromuscular disorders despite the paucity of high‐quality …

Distal symmetric polyneuropathy (DSPN) is the most common neuropathy to occur in
diabetes mellitus. However, patients with diabetes can also develop inflammatory …

Objectives: Small-fiber polyneuropathy (SFPN) has various underlying causes, including
associations with systemic autoimmune conditions. We have proposed a new cause; small …

Guillain-Barré syndrome (GBS) is an acute autoimmune polyradiculoneuropathy affecting 1–
2 subjects per 100,000 every year worldwide. It causes, in its classic form, symmetric …

Over the past 3 decades, IgG has been broadly used as replacement therapy in patients of
all ages with primary antibody deficiencies. Successful use of therapeutic IgG to prevent …

Therapy by human immunoglobulin G (IgG) concentrates is a success story ongoing for
decades with an ever increasing demand for this plasma product. The success of IgG …

Background Arterial and venous thromboembolic events (TEEs) have been associated with
intravenous Ig use, but the risk has been poorly quantified. We aimed to calculate the risk of …